The interrelationship between insulin resistane and Alzheimer development

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Biomedical Science and Engineering

• Publication date

  2013-07-08

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4236/JBISE.2013.67093
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Diagnostic and Statistical Manual of Mental Disorders

  2013cited by this paper
• Alzheimer's disease.

  2011cited by this paper
• Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

  2011cited by this paper
• Clinical practice. Early Alzheimer's disease.

  2010cited by this paper
• [Non-alcoholic steatosis and steatohepatitis].

  2010cited by this paper
• The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics

  2009cited by this paper
• INTRANASAL INSULIN IMPROVES COGNITION AND MODULATES β-AMYLOID IN EARLY AD

  2008cited by this paper
• Insulin resistance and Alzheimer's disease: molecular links & clinical implications.

  2008cited by this paper
• Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease.

  2008cited by this paper
• Glucose neurotoxicity

  2008cited by this paper
• The Damage Signals Hypothesis of Alzheimer's Disease Pathogenesis

  2008cited by this paper
• Intranasal insulin improves cognition and modulates β-amyloid in early AD

  2008cited by this paper
• Molecular connexions between dementia and diabetes.

  2007cited by this paper
• Molecular basis of insulin action.

  2007cited by this paper
• Insulin Resistance in NAFLD: Potential Mechanisms and Therapies

  2007cited by this paper
• Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes.

  2007cited by this paper
• Pathophysiology of nonalcoholic steatohepatitis.

  2006cited by this paper
• Insulin signaling in the central nervous system: learning to survive.

  2006cited by this paper
• Blood–Brain Barrier and Energy Balance

  2006influential reference
• Roles of Cholesterol and Lipids in the Etiopathogenesis of Alzheimer's Disease

  2006cited by this paper
• Inflammation and insulin resistance.

  2006cited by this paper
• Contribution of inflammatory processes to Alzheimer's disease: molecular mechanisms

  2006cited by this paper
• Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: Link to brain reductions in acetylcholine

  2005cited by this paper
• Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets.

  2005cited by this paper
• Insulin signaling, diabetes mellitus and risk of Alzheimer disease

  2005cited by this paper
• Insulin Action Is Facilitated by Insulin-Stimulated Reactive Oxygen Species With Multiple Potential Signaling Targets

  2005cited by this paper
• Peripheral hyperinsulinemia promotes tau phosphorylation in vivo.

  2005cited by this paper
• Alzheimer's disease β‐secretase BACE1 is not a neuron‐specific enzyme

  2005cited by this paper
• Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

  2005cited by this paper
• The role of insulin receptor signaling in the brain.

  2005cited by this paper
• Insulin receptor signaling in long-term memory consolidation following spatial learning.

  2005cited by this paper
• Insulin modulates hippocampal activity‐dependent synaptic plasticity in a N‐methyl‐d‐aspartate receptor and phosphatidyl‐inositol‐3‐kinase‐dependent manner

  2005cited by this paper
• Neuroscience. Brain under surveillance: the microglia patrol.

  2005cited by this paper
• Brain Under Surveillance: The Microglia Patrol

  2005cited by this paper
• Cross-national comparisons of the occurrence of Alzheimer's and vascular dementias

  2005cited by this paper
• Presenilin function and γ‐secretase activity

  2005cited by this paper
• Mechanisms of cell signaling and inflammation in Alzheimer's disease.

  2005cited by this paper
• The source of cerebral insulin.

  2004cited by this paper
• Insulin Resistance Takes a Trip Through the ER

  2004cited by this paper
• Endothelial dysfunction, inflammation, and insulin resistance: A focus on subjects at risk for type 2 diabetes

  2004cited by this paper
• Molecular Pathogenesis of Genetic and Inherited Diseases Induction of Inflammatory Mediators and Microglial Activation in Mice Transgenic for Mutant Human P301S Tau Protein

  2004cited by this paper
• Role for neuronal insulin resistance in neurodegenerative diseases

  2004cited by this paper
• Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma.

  2004cited by this paper
• A possible link between skeletal muscle mitochondrial efficiency and age-induced insulin resistance.

  2004cited by this paper
• Nonalcoholic fatty liver disease in patients with type 2 diabetes.

  2004cited by this paper
• A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

  2004cited by this paper
• Reduced β-Amyloid Production and Increased Inflammatory Responses in Presenilin Conditional Knock-out Mice*

  2004cited by this paper
• Signaling pathways: the benefits of good communication.

  2004cited by this paper
• Insulin in UW solution exacerbates hepatic ischemia / reperfusion injury by energy depletion through the IRS‐2 / SREBP‐1c pathway

  2004cited by this paper
• Deciphering the molecular basis of memory failure in Alzheimer's disease.

  2004cited by this paper
• Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes

  2004cited by this paper
• The microglial phagocytic role with specific plaque types in the Alzheimer disease brain.

  2004cited by this paper
• Diet‐induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease

  2004cited by this paper
• Hyperinsulinemia and risk of Alzheimer disease

  2004cited by this paper
• Role for neuronal insulin resistance in neurodegenerative diseases.

  2004cited by this paper
• An investigation into signal transduction mechanisms involved in insulin‐induced long‐term depression in the CA1 region of the hippocampus

  2004cited by this paper
• Alzheimer disease in the US population: prevalence estimates using the 2000 census.

  2003cited by this paper
• Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic Intervention

  2003cited by this paper
• Insulin and the blood-brain barrier.

  2003cited by this paper
• The Induction of the TNFα Death Domain Signaling Pathway in Alzheimer's Disease Brain

  2003cited by this paper
• Reduced Hippocampal Insulin-Degrading Enzyme in Late-Onset Alzheimer's Disease Is Associated with the Apolipoprotein E-ε4 Allele

  2003cited by this paper
• Reduced hippocampal insulin-degrading enzyme in late-onset Alzheimer's disease is associated with the apolipoprotein E-epsilon4 allele.

  2003cited by this paper
• Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR‐γ ligand rosiglitazone

  2003cited by this paper
• Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.

  2003cited by this paper
• Insulin-degrading enzyme regulates the levels of insulin, amyloid β-protein, and the β-amyloid precursor protein intracellular domain in vivo

  2003cited by this paper
• Inflammation and insulin resistance.

  2003cited by this paper
• Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer's disease: interactions with apolipoprotein E genotype.

  2003cited by this paper
• Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease.

  2003cited by this paper
• Hepatic subcapsular steatosis in response to intraperitoneal insulin delivery: CT findings and prevalence.

  2003cited by this paper
• Astrocytes accumulate Aβ42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains

  2003cited by this paper
• Insulin and leptin revisited: adiposity signals with overlapping physiological and intracellular signaling capabilities.

  2003cited by this paper
• Soluble tumor necrosis factor-alpha receptors in young obese subjects with normal and impaired glucose tolerance.

  2003cited by this paper
• Synaptic Plasticity and AMPA Receptor Trafficking

  2003cited by this paper
• Clinical practice. Early Alzheimer's disease.

  2003cited by this paper
• Mitochondrial Dysfunction in the Elderly: Possible Role in Insulin Resistance

  2003cited by this paper
• Slow Cognitive Decline in Alzheimer’s Disease

  2003cited by this paper
• Polyunsaturated fatty acids ameliorate hepatic steatosis in obese mice by SREBP‐1 suppression

  2003cited by this paper
• Adult mouse astrocytes degrade amyloid-β in vitro and in situ

  2003cited by this paper
• Dynamic regulation of GABA(A) receptors at synaptic sites.

  2002cited by this paper
• Does insulin dysfunction play a role in Alzheimer's disease?

  2002cited by this paper
• Alcoholic steatosis and steatohepatitis.

  2002cited by this paper
• The active form of glycogen synthase kinase-3β is associated with granulovacuolar degeneration in neurons in Alzheimer's disease

  2002cited by this paper
• Ablation of Insulin-Producing Neurons in Flies: Growth and Diabetic Phenotypes

  2002cited by this paper
• Amyloid precursor protein gene disruption attenuates degeneration of substantia nigra compacta neurons following axotomy.

  2002cited by this paper
• Alzheimer's β-Amyloid Peptides Compete for Insulin Binding to the Insulin Receptor

  2002cited by this paper
• Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death.

  2002cited by this paper
• Hypothalamic insulin signaling is required for inhibition of glucose production

  2002cited by this paper
• Reduction of amyloid load and cerebral damage in transgenic mouse model of Alzheimer's disease by treatment with a β‐sheet breaker peptide

  2002cited by this paper
• Amyloid beta-peptide decreases neuronal glucose uptake despite causing increase in GLUT3 mRNA transcription and GLUT3 translocation to the plasma membrane.

  2002cited by this paper
• The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study.

  2002cited by this paper
• Oxidative stress-related molecules and liver fibrosis.

  2001cited by this paper
• Stimulation of β-Amyloid Precursor Protein Trafficking by Insulin Reduces Intraneuronal β-Amyloid and Requires Mitogen-Activated Protein Kinase Signaling

  2001cited by this paper
• The role of TNF and its receptors in Alzheimer's disease.

  2001influential reference
• Is obesity an inflammatory condition?

  2001cited by this paper
• Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities.

  2001cited by this paper
• In-vivo measurement of activated microglia in dementia.

  2001cited by this paper
• Serine phosphorylation of insulin receptor substrate-1: a novel target for the reversal of insulin resistance.

  2001cited by this paper
• Localization and regulation of GLUTx1 glucose transporter in the hippocampus of streptozotocin diabetic rats

  2001cited by this paper
• High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: A potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis

  2001cited by this paper
• Oxidative Damage Is the Earliest Event in Alzheimer Disease

  2001cited by this paper

• Computational modelling of TNFα related pathways regulated by neuroinflammation, oxidative stress and insulin resistance in neurodegeneration

  2020cites this paper
• Effect of 3:7 ratio of Astragalus total saponins and Curcumin on the diabetic nephropathy rats model

  2018cites this paper
• Screening and evaluation of natural compounds for therapeutic application in Alzheimer's disease

  2016cites this paper
• Synthèse et évaluation d'aurones sur des modèles de fibres de tau

  2016cites this paper